India drug regulator’s panel clears Cadila COVID vaccine: Report

1 monat vor
If approved, Zydus Cadila’s vaccine will be the second home-grown shot to get emergency authorisation in India after Bharat Biotech’s Covaxin. The Indian drug regulator’s subject expert committee has recommended emergency use approval for Zydus Cadila’s three-dose COVID-19 vaccine, CNBC-TV18 has …
Aus der Quelle lesen